AF Screening in Patients With Abnormal Echocardiographic Parameters
Recruiting · NCT07278089 · Interventional (participants receive a specific treatment) · Lead sponsor: Tze-Fan Chao
View the official record on ClinicalTrials.gov →Interventions studied
study arm
What this trial is about
To evaluate the feasibility of specific echocardiographic parameters as criteria for AF screening and to determine the AF detection yield of scheduled extended ECG monitoring compared to contemporary care.
Who can take part
Age range
20 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- patients who met any of the following criteria
- LAE: defined as LAD ≥ 45 mm or LAVI \> 34 ml/m2;
- LVH: defined as LV septal or posterior wall thickness ≥ 15 mm;
- E/e' \> 14;
- grade II or III diastolic dysfunction;
- VHD;
- HF: defined as LVEF \< 40% or LVEF ≥40% with clinical presentation compatible with Framingham criteria, New York Heart Association functional classification II-IV, and N-terminal pro-B type natriuretic peptide (NT-proBNP) \> 125 pg/ml.
Exclusion criteria
- Patients with a history of AF or atrial flutter, congenital heart disease, acute coronary syndrome undergoing urgent percutaneous coronary intervention within 3 months, uncontrolled hyperthyroidism, end-stage renal disease, unstable hemodynamic status or any known major comorbidities or medical conditions with expected life expectancy less than 1 year are excluded.
Where it is running
1 location listed.
- Taipei Veterans General Hospital - Taipei, Taiwan